Labshake search
Citations for R&D Systems :
3301 - 3350 of 4069 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... BMDMs were treated with recombinant mouse SPARCL1 (5-20 μg/ml, R&D system, #4547-SL ...
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Neuroscience 2023Quote: ... The medium was supplemented daily with bFGF 20ng/ml (233-FB, R&D Systems), RA 1µg/ml (R2625 ...
-
bioRxiv - Cell Biology 2023Quote: ... or with the addition of 5µg/mL recombinant Periostin (R&D Systems, #2955-F2) overnight at 4°C ...
-
bioRxiv - Cancer Biology 2023Quote: ... in the presence or absence of 300 pg/ml rm-IL21 (R&D Systems). The next day ...
-
bioRxiv - Biophysics 2023Quote: ... containing N2 supplement and 20 ng ml−1 EGF (R&D Systems, MN, USA) at 37°C in a 5% oxygen incubator ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Immunology 2023Quote: ... cells were incubated with 10μg/ml human anti-TNFR1 (clone 16805) (R&D System), 20μg/ml human anti-IFNGR1 (clone GIR208 ...
-
bioRxiv - Cell Biology 2023Quote: ... 30 ng/ml macrophage colony stimulating factor (M-CSF; R&D Systems, Minnesota, USA) and 100 U/ml penicillin/streptomycin (P/S ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was switched to basal medium with 10 ng/mL BMP4 (R&D Systems), 10 ng/mL FGF10 (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... and Human/Mouse/Rat/Chicken anti-PAX7 antibody (MAB1675, R&D Systems, 5μg/ml), both diluted 1:100 ...
-
bioRxiv - Cancer Biology 2023Quote: ... in the presence or absence of 300 pg/ml rm-IL21 (R&D Systems). The next day ...
-
bioRxiv - Cell Biology 2023Quote: ... or with the addition of 5ug/mL recombinant Periostin (R&D Systems, #2955-F2). After 24h incubation ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 40 ng/mL of IFN-λ (R&D Systems 5259-IL, Minneapolis, MN). Stimulated cells were then incubated at 37°C for 72 hours and timepoint samples were collected for IFN-stimulated and mock wells at 0 ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Microbiology 2023Quote: ... Cells were stimulated with IFN-α (500 U/ml, R&D systems 11100-1), IFN-β (500 U/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were permeabilized and stained with 5 μg/ml anti-BrdU (R&D Systems). Samples were imaged with a glycerol-immersion ACS_APO 20x/NA 0.60 objective (Leica ...
-
bioRxiv - Bioengineering 2023Quote: ... and transforming growth factor–β3 (10 ng/ml; 243-B3-200; R&D Systems). On day 1 of culture ...
-
bioRxiv - Immunology 2023Quote: ... C- reactive protein or CRP by ELISA (DY1707, R&D Systems, LLoD 15.6pg/ml); leptin by ELISA (DY398-05 ...
-
bioRxiv - Neuroscience 2024Quote: ... and mouse epidermal growth factor (100 ng/ml) (R&D Systems, #2028-EG-200). Cells were plated in a six-well dish at a density of about 2 retinas per 10cm2 well ...
-
bioRxiv - Immunology 2024Quote: ... or melanin ghost plus 3,000 pg/mL exogenous CXCL8 (#208-IL; R&D Systems). Infections were for 1 h on H292 cell monolayers and for 2 h on primary hAEC ...
-
bioRxiv - Molecular Biology 2024Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Cancer Biology 2024Quote: ... and supplemented L-Gutamine with 100 ng/mL SCF and TPO (R&D Systems). Human leukemia cell lines K562 ...
-
bioRxiv - Cancer Biology 2024Quote: ... a concentration of 10ng/mL of TGFβ1 (R&D Systems,240-B-002/CF), or TNFα (R&D Systems ...
-
bioRxiv - Pathology 2024Quote: ... and 30 ng/ml macrophage colony-stimulating factor (M-CSF) (R&D Systems, MN). After the removal of adherent cells ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-7 (rh IL-7; R&D Systems). PBMCs treated with 0.1ug/mL of SEB were supplemented with 10ng/mL of rh IL-7 alone ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5) 10 ng/ml TGFβ1 (766-MB-005, R&D systems, Minneapolis, MN, US), 6 ...
-
bioRxiv - Molecular Biology 2024Quote: ... with 10 ng/mL mouse stem cell factor (SCF) (R&D Systems, 455-MC), 10 ng/mL mouse granulocyte macrophage colony-stimulating factor (R&D Systems ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/mL mouse granulocyte macrophage colony-stimulating factor (R&D Systems, GM-CSF) (415-ML) ...
-
bioRxiv - Immunology 2024Quote: ... Cultures were then treated with 20 μg/ml DC-SIGN-Fc (R&D Systems), or the indicated concentration of anti-Igκ F(ab’)2 ...
-
bioRxiv - Neuroscience 2024Quote: ... cells were then incubated with 15 μg/mL recombinant mouse GPC1 (R&D Systems) in DMEM supplemented with 20mM HEPES for 1 hour at 37°C ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant rat fractalkine (200 ng/ml; R&D Systems, MN, USA, #537-FT-025/CF) or vehicle (PBS ...
-
bioRxiv - Neuroscience 2021Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). The MN culture medium was replaced every other day for 6 days and the MN cultures were characterized by immunocytochemistry as described below ...
-
bioRxiv - Neuroscience 2020Quote: ... OPCM: N2B27 (no Vitamin A) supplemented with 10 ng/ml rhIGF-1 (R&D Systems), 20 ng/ml rhFGF2 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2019Quote: ... Antibody against CA9 (AF2188; 1 μg/mL) was purchased from R&D Systems (Minneapolis, MN). Antibody against tubulin (T5168 ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Genomics 2020Quote: ... 20 mM HEPES) supplemented with 60 ng/mL recombinant mouse M-CSF (R&D systems). For analysis of proliferation ...
-
bioRxiv - Immunology 2021Quote: ... wells were coated with 30 μg/mL PD-L1-Fc chimera protein (R&D Systems) or 6 μg/mL anti-ICOS (clone C398.4A ...
-
bioRxiv - Neuroscience 2020Quote: ... medium was changed daily using RGC induction media containing SHH (250ng/mL; R&D systems) or SAG (100nM ...
-
bioRxiv - Neuroscience 2020Quote: ... with addition of pen/strep and growth factor bFGF 10 ng/ml (R&D Systems). Medium was changed every third day and cells were enzymatically passaged using Accutase (Gibco) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Immunology 2019Quote: ... CD40L (produced in-house as described 63) supplemented with IL4 (10ng/ml; R&D systems) and IL5 (5ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cell Biology 2021Quote: Microfluidic devices were generated as previously described 42 using 2.5mg/ml Collagen (R&D Systems) for the ECM ...
-
bioRxiv - Biophysics 2020Quote: ... consisting of 5ng/mL of recombinant interleukin-1β (IL-1β, R&D Systems, Minneapolis, MN), 10ng/mL recombinant tumor necrosis factor-α (TNF-α ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng ml−1 of recombinant human TNFα (R&D Systems, 210-TA-020/CF) or a combination of both ...
-
bioRxiv - Developmental Biology 2022Quote: ... SFB-VA is supplemented with 10ng/mL FGF7 (R&D Systems, Cat#251-KG/CF), 3µM CHIR99021 (APExBIO ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).